Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1917 1
1951 1
1962 1
1963 1
1964 6
1965 1
1966 2
1967 4
1968 3
1969 2
1971 2
1972 2
1973 6
1974 5
1975 3
1976 1
1977 4
1978 2
1979 1
1980 3
1982 3
1983 4
1984 3
1985 4
1986 4
1987 8
1988 8
1989 6
1990 10
1991 9
1992 18
1993 24
1994 17
1995 17
1996 15
1997 23
1998 31
1999 27
2000 33
2001 30
2002 40
2003 51
2004 71
2005 56
2006 74
2007 103
2008 98
2009 89
2010 108
2011 123
2012 192
2013 157
2014 194
2015 174
2016 219
2017 232
2018 232
2019 295
2020 359
2021 416
2022 398
2023 378
2024 379
2025 467
2026 251

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,924 results

Results by year

Filters applied: . Clear all
Page 1
Glucagon-like peptide-1 agonists in Parkinson's disease: a meta-analysis.
Abdallah AK, Harb A, Mansour A, Nasreldin A, Hamdy R, Hatem N, Mosad N, Hamouda M, Hamouda A, Arumaithurai K. Abdallah AK, et al. Neurol Sci. 2026 Jul 11;47(8):620. doi: 10.1007/s10072-026-09238-3. Neurol Sci. 2026. PMID: 42432163 Review.
BACKGROUND: Type 2 diabetes and Parkinson's disease (PD) share underlying pathways, including insulin resistance and neuroinflammation. ...The primary motor outcome, the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's
BACKGROUND: Type 2 diabetes and Parkinson's disease (PD) share underlying pathways, including insulin resistance …
Early EEG Detection of Treatable Non-Convulsive Status Epilepticus in Severe COVID-19-Associated Encephalopathy: A Case Report.
Chu YC, Chu CL, Kwan SY. Chu YC, et al. Clin EEG Neurosci. 2026 Jul 9:15500594261467526. doi: 10.1177/15500594261467526. Online ahead of print. Clin EEG Neurosci. 2026. PMID: 42423563
BackgroundPersistent depressed consciousness in severe coronavirus disease 2019 (COVID-19) is commonly attributed to hypoxemia, systemic inflammation, sedative exposure, or metabolic disturbance. ...This diagnostic principle also applies to persistent unexplained encephalo …
BackgroundPersistent depressed consciousness in severe coronavirus disease 2019 (COVID-19) is commonly attributed to hypoxemia, syste …
GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection.
Yang M, Liang Z. Yang M, et al. Front Immunol. 2026 Jun 23;17:1839620. doi: 10.3389/fimmu.2026.1839620. eCollection 2026. Front Immunol. 2026. PMID: 42416049 Free PMC article. Review.
Clinical findings, however, remain inconsistent. Studies in Parkinson's disease have reported encouraging signals, but biomarker evidence for disease modification is still limited. In Alzheimer's disease, clinical trials have produced mixed or n …
Clinical findings, however, remain inconsistent. Studies in Parkinson's disease have reported encouraging signals, but …
Mortality trends and projections for type 2 diabetes with concomitant Parkinson's versus Alzheimer's disease among older United States adults, 1999-2023: A retrospective cohort study.
Zhang T, Ma G, Wang W, Huang Q, Sun S, Yang H, Hong X. Zhang T, et al. Medicine (Baltimore). 2026 Jul 3;105(27):e49321. doi: 10.1097/MD.0000000000049321. Medicine (Baltimore). 2026. PMID: 42411944 Free PMC article.
Although type 2 diabetes mellitus (T2DM) frequently co-occurs with Parkinson's disease (PD) and Alzheimer's disease (AD), a systematic comparison of their combined mortality burdens remains lacking. ...
Although type 2 diabetes mellitus (T2DM) frequently co-occurs with Parkinson's disease (PD) and Alzheimer …
Preoperative GNRI Predicts Postoperative Constipation after Fixation of Extracapsular Hip Fractures in Older Adults.
Guo L, Tian Y, Liu Y, Fu Y, Ma Z, Nan C. Guo L, et al. Geriatr Orthop Surg Rehabil. 2026 Jul 4;17:21514593261466327. doi: 10.1177/21514593261466327. eCollection 2026. Geriatr Orthop Surg Rehabil. 2026. PMID: 42404928 Free PMC article.
Multivariable logistic regression adjusted for age, sex, BMI, diabetes, prior stroke/TIA, Parkinson's disease, time to first mobilization ( 48 h), and total opioid dose (morphine-equivalent dose, MED). ...
Multivariable logistic regression adjusted for age, sex, BMI, diabetes, prior stroke/TIA, Parkinson's disease, t …
Limits to the "Medical Clearance" of Patients Presenting With Psychiatric Changes: A Case Report and Review of the Literature.
Pelc J, Chandler G, Rose R. Pelc J, et al. Case Rep Psychiatry. 2026 Jul 2;2026:7070787. doi: 10.1155/crps/7070787. eCollection 2026. Case Rep Psychiatry. 2026. PMID: 42404730 Free PMC article.
We discuss a case of a 54-year-old woman with a history of schizoaffective disorder and Parkinson's disease who presented with altered mental status, including weakness, falls, medication refusal, and paranoia, heralding medical deterioration. ...She was then …
We discuss a case of a 54-year-old woman with a history of schizoaffective disorder and Parkinson's disease who present …
A convergence of global epidemics: diabetes as a modulator of neurodegenerative and neuro-inflammatory disorders.
Leone L, Kiernan TJ, Kuwabara S, Barnett M, Devenney E, Ahmed RM, Lin CS. Leone L, et al. Front Neurol. 2026 Jun 18;17:1824840. doi: 10.3389/fneur.2026.1824840. eCollection 2026. Front Neurol. 2026. PMID: 42394935 Free PMC article. Review.
Diabetes mellitus (DM) and neurological disorders are rapidly converging global health burdens, driven by population ageing, the growing prevalence of metabolic syndrome, and limited early detection and disease-modifying therapies for many neurological
Diabetes mellitus (DM) and neurological disorders are rapidly converging global health burdens, driven by population ag
In Vitro-Prepared A30P Alpha-Synuclein Fibrils Adopt the Conserved and Disease-Relevant Greek Key Fold.
Milchberg MH, Warmuth OA, Borcik CG, Han R, Harding BD, DeZonia B, Dhavale DD, Pierson JA, Kotzbauer PT, Wright ER, Schwieters CD, Rienstra CM. Milchberg MH, et al. J Phys Chem B. 2026 Jul 2. doi: 10.1021/acs.jpcb.6c02786. Online ahead of print. J Phys Chem B. 2026. PMID: 42389901
The pathological hallmark of Parkinson disease (PD) is the formation of the protein alpha-synuclein (Asyn) into beta-sheet-rich, self-templating fibrils in the brain. ...These structures have not only expanded the library of structures available for computational mo …
The pathological hallmark of Parkinson disease (PD) is the formation of the protein alpha-synuclein (Asyn) into beta-sheet-ric …
Adipokine dysregulation and oxidative stress in type 2 diabetes: Implications for neurodegeneration and neuroprotective eff ects of antidiabetic therapies.
Kashmoola IO, Mohammad SH, Alsaaty MH. Kashmoola IO, et al. Neuropsychopharmacol Hung. 2026 Jun;28(2):102-114. Neuropsychopharmacol Hung. 2026. PMID: 42389857 Free article. Review. English.
BACKGROUND: Neurodegeneration is accelerated by Type 2 diabetes mellitus through adipokine dysregulation, insulin resistance, oxidative stress, and neuroinflammation. This could link metabolic imbalance to Alzheimer's disease, Parkinson's dis
BACKGROUND: Neurodegeneration is accelerated by Type 2 diabetes mellitus through adipokine dysregulation, insulin resistance, …
Amylin at the crossroads of type 2 diabetes and neurodegenerative diseases.
López Del Castillo I, Garcia-Martin J, Gutierrez A, Moreno-Gonzalez I. López Del Castillo I, et al. Ageing Res Rev. 2026 Jul 1;121:103226. doi: 10.1016/j.arr.2026.103226. Online ahead of print. Ageing Res Rev. 2026. PMID: 42386071 Review.
Type 2 diabetes (T2D) is traditionally viewed as a metabolic disease centered on insulin resistance and beta-cell failure. ...Through prion-like cross-seeding, IAPP interacts with Abeta, tau, alpha-synuclein, and PrP, linking T2D as a major risk factor for neurodege …
Type 2 diabetes (T2D) is traditionally viewed as a metabolic disease centered on insulin resistance and beta-cell failure. ... …
4,924 results